Fast Market Research

New Report Available: Qatar Pharmaceuticals & Healthcare Report Q1 2014

New Healthcare research report from Business Monitor International is now available from Fast Market Research

 

Boston, MA -- (ReleaseWire) -- 01/07/2014 -- It is unlikely the Qatari government will respond favourably to the 'discrimination policy' grievances voiced by the local private healthcare insurance industry this quarter. These were voiced in response to the government's decision to use one public insurance company in its mandatory health insurance policy. We believe the government is attempting to streamline healthcare services in the country by providing universal basic healthcare services and gradually shifting the financial burden of growing demand for chronic medicines and complex medical surgeries to the private healthcare sector.

Headline Expenditure Projections

- Pharmaceuticals: QAR1.52bn (US$416mn) in 2012 to QAR1.76bn (US$483mn) in 2013; +16.1% in local currency and US dollar terms. Forecast revised slightly upwards from Q413 due to macroeconomic modifications.
- Healthcare: QAR13.56bn (US$3.72bn) in 2012 to QAR15.26bn (US$4.19bn) in 2013; +12.5% in both local currency and US dollar terms. Forecast revised slightly upwards due to macroeconomic modifications.

View Full Report Details and Table of Contents

Risk/Reward Rating: Qatar's risks are particularly low in comparison with the rest of the MEA region, although its potential rewards are dampened by the small market size. Nevertheless, Qatar's high level of urbanisation, rapid population growth and rising prevalence of chronic lifestyle diseases creates an environment in which there is strong potential for market growth. On account of shifts within BMI's Pharmaceutical Risk/Reward Rating Index for the Middle East and Africa matrix, Qatar has dropped one position to seventh place in our Q114 matrix, although its score has increased to 53 out of 100.

Key Trends And Developments

November 2013

The Qatar Development Bank (QDB) launched a specialised competitive financing resource for companies engaged in healthcare businesses in Qatar according to Zawya. The move aims to promote local private healthcare companies. The QDB's new product will provide loans of up to 80% on easy credit terms, with a maximum repayment tenure of nearly 12 years, to healthcare businesses. Through the new facility, QDB will finance a number of healthcare projects.

Local private healthcare insurers in Qatar have criticised the government-imposed compulsory health insurance policy. Insurers are seeking a greater role in the health insurance plan, and are urging the government to allow them to provide mandatory health insurance for expatriates and visitors, according to local news source, The Peninsula. A senior official of Qatar Insurance Company, the country's largest insurer, referred to the system as a 'discriminatory policy' that restricts private healthcare insurers from providing services.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Malaysia Pharmaceuticals & Healthcare Report Q1 2014
- Russia Pharmaceuticals & Healthcare Report Q1 2014
- Sweden Pharmaceuticals & Healthcare Report Q1 2014
- Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2014
- Estonia Pharmaceuticals & Healthcare Report Q1 2014
- Kenya Pharmaceuticals & Healthcare Report Q1 2014
- Bulgaria Pharmaceuticals & Healthcare Report Q1 2014
- Algeria Pharmaceuticals & Healthcare Report Q1 2014
- Nigeria Pharmaceuticals & Healthcare Report Q1 2014
- Romania Pharmaceuticals & Healthcare Report Q1 2014